Data from a real-world cohort in Italy show female sex is the only independent variable associated with lower probability of achieving LDL target level for every risk category, regardless of whether the patient is prescribed statin therapy.
“Regardless of CV risk category, female gender emerged as strongest independent predictor of failure to achieve LDL targets,” Martina Berteotti, MD, PhD, of the department of experimental and clinical medicine at the University of Florence, Italy, and colleagues wrote in the study background. “This gender disparity has been consistently